HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Khanyisani Ziqubu Selected Research
Khanyisani Ziqubu Research Topics
Disease
15
Inflammation (Inflammations)
02/2024 - 12/2020
10
Insulin Resistance
12/2023 - 01/2019
8
Metabolic Diseases (Metabolic Disease)
01/2024 - 01/2019
6
Type 2 Diabetes Mellitus (MODY)
10/2022 - 10/2021
5
Obesity
01/2024 - 01/2020
4
Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 01/2021
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2022 - 12/2020
3
Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 01/2019
2
Dyslipidemias (Dyslipidemia)
01/2023 - 10/2021
2
Diabetes Complications
01/2022 - 12/2021
2
Hyperglycemia
01/2022 - 01/2020
2
Non-alcoholic Fatty Liver Disease
12/2021 - 12/2020
1
Sarcopenia
11/2023
1
Diabetes Mellitus
02/2023
1
Body Weight (Weight, Body)
01/2023
1
Pain (Aches)
09/2022
1
Diabetic Neuropathies (Diabetic Neuropathy)
09/2022
1
Liver Failure
03/2022
1
Wounds and Injuries (Trauma)
03/2022
1
Reperfusion Injury
03/2022
1
Atherosclerosis
02/2022
1
Prediabetic State (Prediabetes)
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Weight Loss (Weight Reduction)
01/2021
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1
Chemical and Drug Induced Liver Injury
01/2021
1
Necrosis
12/2020
1
Hyperlipidemias (Hyperlipidemia)
01/2020
Drug/Important Bio-Agent (IBA)
8
Antioxidants
IBA
11/2023 - 12/2020
6
C-Reactive Protein
IBA
02/2024 - 01/2021
6
Therapeutic Uses
IBA
09/2022 - 12/2020
5
Lipids
IBA
02/2024 - 12/2020
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2023 - 01/2021
4
Interleukin-6 (Interleukin 6)
IBA
11/2023 - 01/2021
4
Cholesterol
IBA
02/2023 - 01/2022
4
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 06/2020
4
Insulin (Novolin)
FDA Link
05/2022 - 01/2019
4
Blood Glucose (Blood Sugar)
IBA
01/2022 - 01/2019
3
Biomarkers (Surrogate Marker)
IBA
03/2023 - 12/2021
3
Malondialdehyde (Propanedial)
IBA
10/2022 - 12/2021
3
Cysteine (L-Cysteine)
FDA Link
03/2022 - 12/2020
3
Palmitates
IBA
10/2021 - 01/2019
3
homoorientin (isoorientin)
IBA
06/2020 - 01/2020
2
Glutathione (Reduced Glutathione)
IBA
02/2023 - 03/2022
2
Metformin (Glucophage)
FDA Link
Generic
01/2023 - 01/2021
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2023 - 02/2022
2
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2023 - 01/2022
2
epigallocatechin gallate (epigallocatechin-3-gallate)
IBA
08/2022 - 01/2021
2
Interleukins
IBA
01/2022 - 12/2020
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
12/2023
1
AMP-Activated Protein Kinases
IBA
01/2023
1
fibroblast growth factor 21
IBA
01/2023
1
Growth Differentiation Factor 15
IBA
01/2023
1
Mevalonic Acid (Mevalonate)
IBA
01/2023
1
coenzyme Q10 (CoQ10)
IBA
01/2023
1
4-hydroxy-2-nonenal (4-hydroxynonenal)
IBA
10/2022
1
Capsaicin (Zostrix)
FDA Link
09/2022
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
05/2022
1
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
05/2022
1
Nonesterified Fatty Acids (NEFA)
IBA
05/2022
1
Cytokines
IBA
02/2022
1
Free Radicals
IBA
02/2022
1
Thiazolidinediones
IBA
02/2022
1
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
02/2022
1
Mitogen-Activated Protein Kinases
IBA
01/2022
1
NF-kappa B (NF-kB)
IBA
01/2022
1
Powders
IBA
01/2022
1
Quercetin
IBA
01/2022
1
Rutin (Rutoside)
IBA
01/2022
1
Ascorbic Acid (Vitamin C)
FDA Link
Generic
01/2022
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2022
1
3-hydroxyflavone
IBA
01/2022
1
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
01/2022
1
Alanine Transaminase (SGPT)
IBA
12/2021
1
Triglycerides (Triacylglycerol)
IBA
12/2021
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
12/2021
1
Curcumin
IBA
12/2021
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
12/2021
1
Vitamin K
FDA Link
12/2021
1
orientin
IBA
10/2021
1
Tea
IBA
01/2021
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2021
1
oxidized low density lipoprotein
IBA
01/2021
1
Adipokines
IBA
01/2021
1
Protective Agents
IBA
12/2020
1
Pioglitazone (Actos)
FDA Link
06/2020
1
disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylate
IBA
06/2020
1
aspalathin
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
01/2019
1
Flavonoids
IBA
01/2019
1
Protein Kinases (Protein Kinase)
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
01/2019
Therapy/Procedure
2
Therapeutics
02/2022 - 12/2021
1
Highly Active Antiretroviral Therapy (HAART)
02/2024
1
Rejuvenation
01/2024
1
Glycemic Control
10/2022
1
Caloric Restriction
05/2022
1
Transplantation
03/2022
1
Liver Transplantation
03/2022
1
Secondary Prevention
01/2021